Modulation Of Putative Surrogate Endpoint Biomarkers In Endometrial Biopsies From Women With HNPCC.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Ethinylestradiol/norgestrel; Medroxyprogesterone
- Indications Endometrial cancer
- Focus Biomarker; Therapeutic Use
- 03 May 2013 Biomarkers information updated
- 17 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Aug 2012 Planned end date changed from 1 Feb 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.